Study shows promise for smokers trying to quit

The use of the antidepressant, sustained release (SR) bupropion, triples quit rates among women and smokers with a history of depression as compared to placebo, according to a new study just published in Nicotine and Tobacco Research by researchers at the Center for Tobacco Research and Intervention. Historically, women and formerly depressed smokers are at particularly high risk of relapse.